Polyvinyl Alcohol
Active ingredient
Sold as MURINE · REFRESH · DIOROUGE LIQ · Clear Eyes Triple Relief · ARTIFICIAL TEARS FOR DRY…
- Drug class
- -
- Availability
- Over-the-counter
- Routes
- Ophthalmic
- Markets covered
- 2
- Products on record
- 5
- FDA reports (12 mo)
- 457
Overview
Plain-language summary, compiled from the cited regulatory records
Polyvinyl Alcohol is an active ingredient used in eye drops [1]. It is approved for use as a protectant against further irritation or to relieve dryness of the eye [1]. It provides temporary relief of discomfort due to minor eye irritations, or from exposure to wind or sun [1].
This ingredient is available in various over-the-counter products. Examples of brands that contain Polyvinyl Alcohol include Clear Eyes Triple Relief [1].
In the past 12 months, there have been 457 adverse event reports associated with products containing Polyvinyl Alcohol [2]. The most frequently reported reactions include eye pain, eye irritation, dry eye, cataract, and headache [2].
This is not medical advice. Consult a qualified healthcare professional.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| US United States | FDA | 2 | December 30, 2025 |
| CA Canada | Health Canada | 3 | March 22, 2025 |
USUnited States· FDA
2 products
Uses
Uses for use as a protectant against further irritation or to relieve dryness of the eye for the temporary relief of discomfort due to minor irritations of the eye, or to exposure to wind or sun
How to take
CACanada· Health Canada
3 products
3 products on record with this regulator. Detailed label text (uses, dosage, side effects) is being ingested — the original document is linked under Sources [2].
Sources & citations
- [1]FDA DailyMed · 081673b2-5c74-12… · revised December 30, 2025 [PDF]
- [2]Health Canada (DPD) · 02138670 · revised March 22, 2025
- [3]OpenFDA adverse-event reports (US), 12 months ending June 4, 2026.
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.